Elong Power Prices 4.615 Million Unit Public Offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 38 minutes ago
0mins
Should l Buy ELPW?
Source: PRnewswire
- Offering Pricing: Elong Power successfully priced its public offering of 4.615 million units at $1.30 per unit, expecting gross proceeds of approximately $6 million, which will significantly support the company's working capital and product development initiatives.
- Warrant Details: Each unit includes one ordinary share and a common warrant, with the exercise price equal to the offering price, which will be immediately exercisable upon issuance, potentially increasing investor engagement and interest.
- Offering Timeline: The offering is expected to close on May 18, 2026, subject to customary closing conditions outlined in the Securities Purchase Agreements, ensuring a smooth completion of the offering process.
- Strategic Development Focus: Elong Power is dedicated to the R&D and sales of lithium battery energy storage systems, planning to use the proceeds from the offering to expand production capacity and iterate on products to meet the growing global demand for efficient energy storage solutions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ELPW?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ELPW
About ELPW
eLong Power Holding Ltd is a holding company principally engaged in the research and development, manufacturing, sales, and service of high-power lithium-ion batteries and related systems. The Company’s main businesses include the production of high-power lithium-ion batteries for electric vehicles and construction machinery, as well as large-capacity, long-cycle lithium-ion batteries for energy storage systems. The Company’s product and technology system covers battery cells, modules, system integration, and battery management system (BMS) development. The Company’s product portfolio includes lithium manganese oxide and lithium iron phosphate batteries and others, designed for high-power applications and energy storage scenarios.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Elong Power Prices 4.615 Million Unit Public Offering
- Offering Pricing: Elong Power successfully priced its public offering of 4.615 million units at $1.30 per unit, expecting gross proceeds of approximately $6 million, which will significantly support the company's working capital and product development initiatives.
- Warrant Details: Each unit includes one ordinary share and a common warrant, with the exercise price equal to the offering price, which will be immediately exercisable upon issuance, potentially increasing investor engagement and interest.
- Offering Timeline: The offering is expected to close on May 18, 2026, subject to customary closing conditions outlined in the Securities Purchase Agreements, ensuring a smooth completion of the offering process.
- Strategic Development Focus: Elong Power is dedicated to the R&D and sales of lithium battery energy storage systems, planning to use the proceeds from the offering to expand production capacity and iterate on products to meet the growing global demand for efficient energy storage solutions.
See More
Elong Power Prices Offering of 4.615 Million Units
- Offering Size: Elong Power announced the pricing of 4,615,500 units at $1.30 each, with expected gross proceeds of approximately $6 million, indicating the company's confidence in future growth as the funds will be allocated for working capital and product development.
- Warrant Details: Each unit consists of one ordinary share and a common warrant with an exercise price of $1.30, which includes anti-dilution provisions, enhancing investor appeal by protecting their interests in future financing rounds.
- Underwriting Arrangement: Maxim Group LLC acts as the sole placement agent for the offering, ensuring professionalism and compliance throughout the issuance process, while Ortoli Rosenstadt LLP and Pryor Cashman LLP serve as legal counsel, safeguarding the transaction's legal integrity.
- Closing Timeline: The offering is expected to close on May 18, 2026, subject to customary closing conditions outlined in the Securities Purchase Agreements, reflecting the company's active engagement in the capital markets and commitment to transparency with investors.
See More
U.S. Stocks Rise in Morning Trade Amid Economic Slowdown
- Dow Jones Surge: The Dow Jones Industrial Average gained over 300 points on Friday, rising 0.68% to 46,995.67, indicating a positive market reaction to economic data that may boost investor confidence.
- NASDAQ and S&P 500 Performance: The NASDAQ rose 0.40% to 22,401.88, while the S&P 500 increased by 0.50% to 6,706.16, reflecting strong performances in tech and large-cap stocks, suggesting optimism about future growth.
- Economic Growth Slowdown: According to the Bureau of Economic Analysis, the GDP growth rate for Q4 2025 was revised down to 0.7% from an initial estimate of 1.4%, marking a sharp deceleration from the 4.4% growth pace in Q3, highlighting concerns about economic momentum.
- Commodity Market Fluctuations: Oil prices fell by 1.7% to $94.11, and gold dipped 0.2% to $5,118.00 on Friday, indicating that uncertainties about the economic outlook are impacting commodity prices, potentially leading investors to reassess risks.
See More
The Oncology Institute Reports Strong Q4 Results, Shares Surge
- Earnings Beat: The Oncology Institute reported a Q4 loss of 6 cents per share, outperforming the analyst consensus estimate of a 9-cent loss, indicating improvements in cost management and operational efficiency, which boosts market confidence in its future profitability.
- Sales Growth: The company achieved quarterly sales of $141.957 million, exceeding the analyst consensus of $139.775 million, reflecting positive progress in market demand and product promotion, thereby strengthening its market position in oncology treatment.
- Stock Surge: Shares of The Oncology Institute jumped 14.7% to $3.01 in pre-market trading, demonstrating a positive investor reaction to the financial results, which may attract more investor interest in its future developments.
- Increased Market Confidence: The better-than-expected performance not only enhances investor confidence but may also prompt analysts to reassess the company's long-term growth potential, potentially influencing future stock price movements and market performance.
See More
eLong Power Shares Surge 45.13% After Reverse Stock Split
- Reverse Stock Split Effective: eLong Power Holding Ltd. executed an 80-for-1 reverse stock split on Thursday, resulting in a 45.13% surge in after-hours trading to $5.21, despite a 14.20% drop to $3.59 during regular trading, indicating a positive market reaction to the split.
- Shareholder Meeting Decision: According to an SEC filing, the board approved the share consolidation on March 5 to ensure compliance with Nasdaq listing rules, aiming to maintain a closing bid price above $0.10, thereby enhancing market confidence.
- Significant Reduction in Shares: Following the split, eLong's outstanding shares decreased from approximately 63 million to about 790,000, with no substantial change in individual shareholder ownership percentages, potentially increasing the attractiveness of earnings per share.
- Market Performance Analysis: eLong Power has a market capitalization of $425.76 million, with a staggering 99.59% decline in stock price over the past 12 months, currently positioned near its 52-week low, reflecting a negative long-term outlook despite a short-term rebound due to the split.
See More
U.S. Stocks Decline Amid Weak Retail Sales Data
- Market Performance: U.S. stocks broadly declined during trading, with the S&P 500 falling approximately 1%, the Dow down 0.99% to 47,479.25, and the NASDAQ dropping 0.86% to 22,554.26, indicating market concerns over economic outlook.
- Retail Sales Data: U.S. retail sales fell by 0.2% month-over-month in January, missing market estimates of a 0.3% decline, reflecting weak consumer spending that could negatively impact economic growth.
- Sector Movements: While the overall market declined, energy stocks rose by 0.5%, contrasting with a 2.1% drop in financial stocks, indicating sector divergence that may influence investor asset allocation strategies.
- International Market Dynamics: European shares fell broadly, with the eurozone's STOXX 600 down 1.04%, while Asian markets mostly gained, suggesting varying performances across regions that could affect global investor confidence.
See More
Elong Power Prices 4.615 Million Unit Public Offering
- Offering Pricing: Elong Power successfully priced its public offering of 4.615 million units at $1.30 per unit, expecting gross proceeds of approximately $6 million, which will significantly support the company's working capital and product development initiatives.
- Warrant Details: Each unit includes one ordinary share and a common warrant, with the exercise price equal to the offering price, which will be immediately exercisable upon issuance, potentially increasing investor engagement and interest.
- Offering Timeline: The offering is expected to close on May 18, 2026, subject to customary closing conditions outlined in the Securities Purchase Agreements, ensuring a smooth completion of the offering process.
- Strategic Development Focus: Elong Power is dedicated to the R&D and sales of lithium battery energy storage systems, planning to use the proceeds from the offering to expand production capacity and iterate on products to meet the growing global demand for efficient energy storage solutions.
See More
Elong Power Prices Offering of 4.615 Million Units
- Offering Size: Elong Power announced the pricing of 4,615,500 units at $1.30 each, with expected gross proceeds of approximately $6 million, indicating the company's confidence in future growth as the funds will be allocated for working capital and product development.
- Warrant Details: Each unit consists of one ordinary share and a common warrant with an exercise price of $1.30, which includes anti-dilution provisions, enhancing investor appeal by protecting their interests in future financing rounds.
- Underwriting Arrangement: Maxim Group LLC acts as the sole placement agent for the offering, ensuring professionalism and compliance throughout the issuance process, while Ortoli Rosenstadt LLP and Pryor Cashman LLP serve as legal counsel, safeguarding the transaction's legal integrity.
- Closing Timeline: The offering is expected to close on May 18, 2026, subject to customary closing conditions outlined in the Securities Purchase Agreements, reflecting the company's active engagement in the capital markets and commitment to transparency with investors.
See More
U.S. Stocks Rise in Morning Trade Amid Economic Slowdown
- Dow Jones Surge: The Dow Jones Industrial Average gained over 300 points on Friday, rising 0.68% to 46,995.67, indicating a positive market reaction to economic data that may boost investor confidence.
- NASDAQ and S&P 500 Performance: The NASDAQ rose 0.40% to 22,401.88, while the S&P 500 increased by 0.50% to 6,706.16, reflecting strong performances in tech and large-cap stocks, suggesting optimism about future growth.
- Economic Growth Slowdown: According to the Bureau of Economic Analysis, the GDP growth rate for Q4 2025 was revised down to 0.7% from an initial estimate of 1.4%, marking a sharp deceleration from the 4.4% growth pace in Q3, highlighting concerns about economic momentum.
- Commodity Market Fluctuations: Oil prices fell by 1.7% to $94.11, and gold dipped 0.2% to $5,118.00 on Friday, indicating that uncertainties about the economic outlook are impacting commodity prices, potentially leading investors to reassess risks.
See More
The Oncology Institute Reports Strong Q4 Results, Shares Surge
- Earnings Beat: The Oncology Institute reported a Q4 loss of 6 cents per share, outperforming the analyst consensus estimate of a 9-cent loss, indicating improvements in cost management and operational efficiency, which boosts market confidence in its future profitability.
- Sales Growth: The company achieved quarterly sales of $141.957 million, exceeding the analyst consensus of $139.775 million, reflecting positive progress in market demand and product promotion, thereby strengthening its market position in oncology treatment.
- Stock Surge: Shares of The Oncology Institute jumped 14.7% to $3.01 in pre-market trading, demonstrating a positive investor reaction to the financial results, which may attract more investor interest in its future developments.
- Increased Market Confidence: The better-than-expected performance not only enhances investor confidence but may also prompt analysts to reassess the company's long-term growth potential, potentially influencing future stock price movements and market performance.
See More
eLong Power Shares Surge 45.13% After Reverse Stock Split
- Reverse Stock Split Effective: eLong Power Holding Ltd. executed an 80-for-1 reverse stock split on Thursday, resulting in a 45.13% surge in after-hours trading to $5.21, despite a 14.20% drop to $3.59 during regular trading, indicating a positive market reaction to the split.
- Shareholder Meeting Decision: According to an SEC filing, the board approved the share consolidation on March 5 to ensure compliance with Nasdaq listing rules, aiming to maintain a closing bid price above $0.10, thereby enhancing market confidence.
- Significant Reduction in Shares: Following the split, eLong's outstanding shares decreased from approximately 63 million to about 790,000, with no substantial change in individual shareholder ownership percentages, potentially increasing the attractiveness of earnings per share.
- Market Performance Analysis: eLong Power has a market capitalization of $425.76 million, with a staggering 99.59% decline in stock price over the past 12 months, currently positioned near its 52-week low, reflecting a negative long-term outlook despite a short-term rebound due to the split.
See More
U.S. Stocks Decline Amid Weak Retail Sales Data
- Market Performance: U.S. stocks broadly declined during trading, with the S&P 500 falling approximately 1%, the Dow down 0.99% to 47,479.25, and the NASDAQ dropping 0.86% to 22,554.26, indicating market concerns over economic outlook.
- Retail Sales Data: U.S. retail sales fell by 0.2% month-over-month in January, missing market estimates of a 0.3% decline, reflecting weak consumer spending that could negatively impact economic growth.
- Sector Movements: While the overall market declined, energy stocks rose by 0.5%, contrasting with a 2.1% drop in financial stocks, indicating sector divergence that may influence investor asset allocation strategies.
- International Market Dynamics: European shares fell broadly, with the eurozone's STOXX 600 down 1.04%, while Asian markets mostly gained, suggesting varying performances across regions that could affect global investor confidence.
See More
